68Table 68.1 Anti‐amyloid monoclonal antibodies in Alzheimer’s disease.Table 68.2 Ongoing AD trials with anti‐tau drugs.Table 68.3 Ongoing clinical trials in AD with mesenchymal stem cells.Table 68.4 Ongoing Trials in preclinical stages of AD.57 Chapter 69Table 69.1 Causes of dementia other than Alzheimer’s disease.Table 69.2 Subtypes of vascular dementia (VaD).Table 69.3 NINDS‐AIREN criteria for probable and possible vascular dementia ...Table 69.4 Characteristics of cortical and subcortical dementia.Table 69.5 Diagnostic criteria for dementia with Lewy bodies (DLB).Table 69.6 Diagnostic criteria for Parkinson’s disease with dementia (PDD).Table 69.7 Distinguishing features between frontotemporal dementia and Alzhe...Table 69.8 Causes of parkinsonism with cognitive impairment in the elderly.
58 Chapter 70Table 70.1 Provisional IPA definition criteria for agitation.Table 70.2 Summary of recommended pharmacological treatments for neuropsychi...Table 70.3 The DICE approach.
59 Chapter 71Table 71.1 Adaptations of psychotherapy for older adults.
60 Chapter 72Table 72.1 Common mental health disorders in older adults.Table 72.2 Common standardized scales recommended in primary care.Table 72.3 CAGE questionnaire.Table 72.4 Members of an ideal interdisciplinary mental health team.Table 72.5 Clinical pearls regarding psychological aspects of rational depre...Table 72.6 ATMAN approach to management of chronic non‐cancer pain.Table 72.7 Examples of evidence‐based prevention in geriatric psychiatry.
61 Chapter 74Table 74.1 Conditions that occur commonly in adults with Down syndrome.Table 74.2 Presentation of spinal cord compression in people with Down syndr...Table 74.3 Approximate prevalence of Alzheimer’s disease in people with Down...
62 Chapter 75Table 75.1 Causes of dizziness in the elderly.Table 75.2 Characteristics of positional nystagmus.Table 75.3 Drugs causing dizziness/vertigo.
63 Chapter 76Table 76.1 Classification of smell disorders.
64 Chapter 78Table 78.1 Medication classes associated with an increased risk of falls in ...Table 78.2 Fall risk factors.
65 Chapter 79Table 79.1 Recommendations for avoiding the dislocation of a hip prosthesis.Table 79.2 Summary of fall risk assessment and appropriate interventions.
66 Chapter 81Table 81.1 Trends in total circulating content of some major hormones with a...Table 81.2 Effects of obesity and positive energy balance on nine hallmarks ...Table 81.3 Effects of testosterone in older men and postmenopausal women.Table 81.4 Lessons from growth hormone studies in older people.Table 81.5 Ghrelin and ageing.
67 Chapter 82Table 82.1 Pituitary cell types, their hormones, and their percentages.Table 82.2 Symptoms of acromegaly in older people with GH secreting tumours.Table 82.3 Symptoms of hypopituitarism in older adults.Table 82.4 Causes of hypopituitarism.Table 82.5 Changes reported in hormones.Table 82.6 Causes of central diabetes insipidus.
68 Chapter 83Table 83.1 Agents that inhibit thyroid hormone synthesis and secretion.Table 83.2 Compounds that affect thyroid hormone transport proteins in serum...Table 83.3 Agents that alter the extrathyroidal metabolism of thyroid hormon...Table 83.4 Drugs that cause false results for thyroid tests in euthyroid peo...Table 83.5 Possible mechanisms of nonthyroidal illness (NTI).Table 83.6 Categories and risk of malignancy of thyroid nodules ultrasound f...
69 Chapter 84Table 84.1 The dose range commonly used in hormone therapy for estradiol and...
70 Chapter 85Table 85.1 Androgen Deficiency in Aging Male (ADAM) questionnaire.Table 85.2 Contraindications for TRT.
71 Chapter 86Table 86.1 Risk factors for diabetes mellitus in older subjects.Table 86.2 Varying presentation of diabetes in older people.Table 86.3 Risk factors for foot ulceration in the elderly.Table 86.4 Benefits of early recognition of cognitive impairment in diabetes...Table 86.5 Benefits of functional assessment: diabetes‐related.Table 86.6 Criteria for targeting patients with type 2 diabetes for comprehe...Table 86.7 Modern aims in managing older people with diabetes.Table 86.8 Care plan for initial management of diabetes in an elderly person...Table 86.9 Key intensive glucose control and other studies with relevance to...Table 86.10 Concerns and deficiencies in diabetes care – institutional facil...Table 86.11 Importance of early detection of diabetes mellitus in care homes...Table A.1 Clinical guidelines and guidance for diabetes care in care homes.
72 Chapter 87Table 87.1 Approved T2DM antiglycaemic therapies.Table 87.2 GLP‐1 agonist and DPP4 inhibitor comparisons.Table 87.3 GLP‐1 agonist comparisons.Table 87.4 Effects of antiglycaemic drugs on hypoglycaemia, weight, and CVD ...Table 87.5 Multifactorial approach to diabetes treatment (ESC 2019 guideline...Table 87.6 Antiglycaemics in development.
73 Chapter 88Table 88.1 Causes of postmenopausal bleeding.Table 88.2 Causes of discharge per vagina.Table 88.3 Health factors that inhibit sexual activity in elderly people.
74 Chapter 89Table 89.1 AUA benign prostatic hyperplasia symptom score.Table 89.2 Table of corresponding Gleason score and ISUP grade.Table 89.3 Groups of D’Amico et al.Table 89.4 Prostate tumour node metastasis (TNM) classification.
75 Chapter 90Table 90.1 Anatomical changes of the ageing bladder.Table 90.2 Bladder receptors and ageing.
76 Chapter 92Table 92.1 Recommendations for cancer screening in older adults.
77 Chapter 93Table 93.1 Summary of oncological emergencies.Table 93.2 Initial antibiotic therapy of neutropenic fever.Table 93.3 Diagnostic criteria of the syndrome of inappropriate antidiuretic...Table 93.4 Main predisposing and precipitating factors of delirium.
78 Chapter 94Table 94.1 TNM stage (%) with age at presentation.Table 94.2 Result of UK breast cancer screening.Table 94.3 Rates of examination and mammography by intervention.
79 Chapter 95Table 95.1 Five leading causes of death: US men and women age 60 and older,...Table 95.2 Five most common sites of cancer mortality: US adults, 2009.Table 95.3 Percentage 5+ year survival by cancer site, US adults 1996–2004.Table 95.4 A proposed algorithm for exercise prescription for older adult c...
80 Chapter 96Table 96.1 Measurable dimensions of geriatric assessment with examples of s...
81 Chapter 97Table 97.1 Comparison of three frailty scales.Table 97.2 MEALS‐ON‐WHEELS mnemonic for treatable causes of weight loss.Table 97.3 Selective androgen receptor molecules.Table 97.4 An approach to the management of frailty using the FRAIL screen.
82 Chapter 98Table 98.1 Determinants of activity and participation restrictions.Table 98.2 Steps in the rehabilitation process.Table 98.3 Standardised functional assessment scales for elderly patients.Table 98.4 The four phases of cardiac rehabilitation.Table 98.5 Elements of pulmonary rehabilitation.
83 Chapter 100Table 100.1 WHO ICOPE screening tool.Table 100.2 Approach, assessment and intervention in each intrinsic capacit...
84 Chapter 102Table 102.1 Specific antimicrobial therapy for meningitis.Table 102.2 Recommended dosages of selected antimicrobial agents for centra...Table 102.3 Empirical antimicrobial therapy of bacterial brain abscess.Table 102.4 Antimicrobial therapy of brain abscess.
85 Chapter 104Table 104.1 Hazard ratios (with 95% CI) of dementia according to alcohol co...Table 104.2 Odds (with 95% CI) of incident dementia according to alcohol co...
86 Chapter 106Table 106.1 Example of monitoring criteria for treatment follow‐up.
87 Chapter 107Table 107.1 Sample diseases for which appropriate assessment and remediatio...Table 107.2 Schematic outline of a driving assessment.
88 Chapter 109Table 109.1
